The Watchman Letter: Biotech Companies Stock Buy Backs programs ROI loses 100 Billion in 2018
I've posted many articles on the once illegal practice of Stock Buy Backs. CEO's borrowing money from the Bond Market to purchase stocks via their Stock Buy Back programs. The frenzy of $5.1 Trillion in SBB since 2009 has weaken Corporate Balance Sheets and will hurt Investors ROI. The Zombie Corporations kept alive by low interest rates will start falling into Bankruptcy as interest rates rise. Below is an article from Marketwatch.com " Big biotech companies have flushed $100 billion in stock buybacks down the toilet" it is research by Geoffrey Porges from Leerink